Influence of department volume on cancer survival for gynaecological cancers-A population-based study in Tyrol, Austria

Gynecologic Oncology

Volumn 103, Issue 2, 2006, Pages 527-534

  Oberaigner, Willi ^a,b   Stühlinger, Wolf ^b  

^a Cancer Registry of Tyrol   (Austria)

^b UNIVERSITY FOR HEALTH SCIENCES   (Austria)

Author keywords

Cancer epidemiology; Department volume; Gynaecological cancer; Minimum caseload; Survival rate

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRIA; BREAST CANCER; CANCER LOCALIZATION; CANCER REGISTRY; CANCER SURVIVAL; CONFIDENCE INTERVAL; DATA ANALYSIS; DATA BASE; FEMALE; GYNECOLOGIC CANCER; HISTOLOGY; HUMAN; HUMAN TISSUE; INCIDENCE; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MORTALITY; OBSERVATIONAL STUDY; OVARY CANCER; PATIENT REFERRAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; UTERINE CERVIX CANCER; UTERUS CANCER; VALIDITY;

AGED; AUSTRIA; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; ONCOLOGY SERVICE, HOSPITAL;

EID: 33750184545     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.03.044     Document Type: Article

References (26)

1. Hillner B.E., Smith T.J., and Desch C.E. Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care. J Clin Oncol 18 11 (2000) 2327-2340
2. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas B. Cancer incidence in five continents. Volume VIII. IARC Scientific Publications No. 155 Lyon: IARC, 2002.
3. Jensen O.M., Parkin D.M., MacLennan R., Muir C.S., and Skeet R.G. Cancer registration. Principles and methods (1991), IARC, Lyon
4. Oberaigner W., and Stühlinger W. Record linkage in the cancer registry of Tyrol. Methods Inf Med 44 5 (2005) 626-630
5. StataCorp. Stata Statistical Software: Release 8 (2003), StataCorp LP, College Station, TX
6. Cleves M., Gould W., and Gutierrez R. An introduction to survival analysis using Stata, Revised edition (2004), Stata Press
7. Wittekind Ch., and Wagner G. TNM Klassifikation maligner Tumoren. 5. Auflage (1997), Springer-Verlag, Berlin
8. Katalinic A., Holzmann M., Uhlenkamp T., Bartel C., and Raspe H. Krebs in Schleswig-Holstein 1998. Lübeck: Institut für Krebsepidemiologie i.V.-Registerstelle des Krebsregisters Schleswig-Holstein (2000)
9. Schmidtmann I., Husmann G., Krtschil G., and Seebauer G. Krebs in Rheinland-Pfalz: Inzidenz und Mortalität im Jahr 2000 (2002), Krebsregister Rheinland-Pfalz, Mainz
10. Vercelli M., Capocaccia R., Quaglia A., Casella C., Puppo A., and Coeberg J.W. Relative survival in elderly European cancer patient: evidence for health care inequalities. The EUROCARE working group. Crit Rev Oncol Hematol 35 3 (2000) 161-179
11. Roohan P.J., Bickell N.A., Baptiste M.S., Therriault G.D., Ferrara E.P., and Siu A.L. Hospital volume differences and five-year survival from breast cancer. Am J Public Health 88 3 (1998) 454-457
12. Skinner K.A., Helsper J.T., Deapen D., Ye W., and Sposto R. Breast cancer: do specialists make a difference?. Ann Surg Oncol 10 6 (2003) 606-615
13. Gillis C.R., and Hole D.J. Survival outcome of care by specialist surgeons in breast cancer: a study of 3786 patients in the west of Scotland. BMJ 312 7024 (1996) 145-148
14. Calman K, Hine D. Policy framework for commissioning cancer services: a report by the Expert Advisory Group on Cancer to the Chief Medical Officers of England and Wales. Department of Health. London HM Stationary Office; 1995.
15. Improving outcomes in breast cancer: guidance for purchasers (1996), Department of Health, London
16. Sevelda P., Obermair A., Oberaigner W., and Marth C. Qualitätserfassung bei Ovarialkarzinom. Krebs! Hilfe! 4 (2004) 48-49
17. Elit L., Bondy S.J., Paszat L., Przybysz R., and Levine M. Outcomes in surgery for ovarian cancer. Gynecol Oncol 87 3 (2002) 260-267
18. Woodman C., Baghdady A., Collins S., and Clyma J.A. What changes in the organisation of cancer services will improve the outcome for women with ovarian cancer?. Br J Obstet Gynaecol 104 2 (1997) 135-139
19. Ioka A., Tsukuma H., Ajiki W., and Oshima A. Influence of hospital procedure volume on ovarian cancer survival in Japan, a country with low incidence of ovarian cancer. Cancer Sci 95 3 (2004) 233-237
20. Kumpulainen S., Grenman S., Kyyronen P., Pukkala E., and Sankila R. Evidence of benefit from centralised treatment of ovarian cancer: a nationwide population-based survival analysis in Finland. Int J Cancer 102 5 (2002) 541-544
21. Du Bois B.A., Rochon J., Lamparter C., and Pfisterer J. Pattern of care and impact of participation in clinical studies on the outcome in ovarian cancer. Int J Gynecol Cancer 15 2 (2005) 183-191
22. Wolfe C.D., Tilling K., and Raju K.S. Management and survival of ovarian cancer patients in south east England. Eur J Cancer 33 11 (1997) 1835-1840
23. Improving outcomes in gynecological cancers: the research evidence (1999), NHS Executive, Department of Health, London
24. National Cancer Guidance Steering Group: improving outcomes in gynecological cancers: the manual (1999), NHS Executive, Department of Health, London
25. Fighting the silent killer: optimizing ovarian cancer management in Scotland. Accounts Commission for Scotland: The Commission; 1998.
26. Guidelines for referral to a gynecologic oncologist: rationale and benefits. The Society of Gynecologic Oncologists. Gynecol Oncol 78 3 Pt 2 (2000) S1-S13